Metagenomi Therapeutics, Inc. (MGX)

NASDAQ: MGX · Real-Time Price · USD

1.230

+0.010 (0.82%)

At close: Aug 13, 2026, 4:00 PM EDT

1.210

-0.020 (-1.63%)

After-hours: Aug 13, 2026, 7:45 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Developing Curative Therapeutics for Patients	25.21M	52.30M	44.76M	17.20M	243.00K
Total	25.21M	52.30M	44.76M	17.20M	243.00K

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	25.21M	52.30M	44.76M	17.20M	243.00K
Total	25.21M	52.30M	44.76M	17.20M	243.00K